Brookfield Corp’s Transmedics TMDX Stock Holding History

Brookfield Corp’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,148	Closed	-$424K	–	740
2022 Q3	$424K	Buy	+10,148	New	+$441K	﹤0.01%	580

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCP

Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brookfield Corp's TMDX Position: Q4 2022 in Review

Brookfield Corp sold out of Transmedics (TMDX) in Q4 2022, closing a stake of 10,148 shares — an estimated $424K sold.

Brookfield Corp first reported a position in TMDX in Q3 2022 and held it in 1 quarter. The position peaked at $424K in Q3 2022. 199 funds tracked by Wall St. Rank hold TMDX as of Q4 2022.

Brookfield Corp reported no remaining Transmedics position as of Q4 2022 after selling out during the quarter.
Brookfield Corp sold 10,148 Transmedics shares in Q4 2022, an estimated $424K.
Brookfield Corp first reported a position in Transmedics in Q3 2022 and held it in 1 quarter.
Brookfield Corp's Transmedics position peaked at $424K in Q3 2022.
199 funds tracked by Wall St. Rank held Transmedics as of Q4 2022.

Based on Brookfield Corp's 13F filing for Q4 2022, filed 14 Feb 2023.